SEC Form 4 · accession 0001628280-26-062239
Ginkgo Bioworks Holdings, Inc. · DNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christian O Henry
Director
Period of report
Sep 15, 2026
Accepted (ET)
Sep 16, 2026 · 4:06 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001830214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Sep 15, 2026 | S | 5,000 | $7.081 | D | 19,310 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.074 to $7.085, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.